Ayala Pharmaceuticals, Inc. License Agreements
3 Contracts & Agreements
- License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company, as amended (Filed With SEC on May 4, 2020)
- Evaluation, Option and License Agreement, dated December 19, 2018, between the Registrant and Novartis International Pharmaceutical Limited (Filed With SEC on March 6, 2020)
- License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company (Filed With SEC on March 6, 2020)
